239 related articles for article (PubMed ID: 18814093)
1. [Combination therapy in patients with pulmonary arterial hypertension].
Ewert R; Opitz CF; Schäper C; Gläser S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S187-90. PubMed ID: 18814093
[TBL] [Abstract][Full Text] [Related]
2. [Drug combination treatment for pulmonary arterial hypertension].
Ghofrani HA; Hoeper MM
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S330-3. PubMed ID: 17139600
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
4. [Bosentan and chronic thromboembolic pulmonary hypertension].
Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
[No Abstract] [Full Text] [Related]
5. Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension.
Gürakan B; Kayiran P; Oztürk N; Kayiran SM; Dindar A
Pediatr Pulmonol; 2011 Jun; 46(6):617-20. PubMed ID: 21438177
[TBL] [Abstract][Full Text] [Related]
6. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
[No Abstract] [Full Text] [Related]
7. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil in the treatment of pulmonary hypertension.
Barnett CF; Machado RF
Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
[TBL] [Abstract][Full Text] [Related]
10. Combination drug therapy in the management of pulmonary arterial hypertension.
Kayser SR
Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
[No Abstract] [Full Text] [Related]
11. Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.
Catapano-Minotti G; Corsonello A; Guadalupi G; Spani R; Antonelli-Incalzi R
Intern Med; 2008; 47(6):511-3. PubMed ID: 18344637
[TBL] [Abstract][Full Text] [Related]
12. Should we administer sildenafil to patients with obstructive pulmonary disease and pulmonary hypertension? No.
Namendys-Silva SA; Hernández-Garay M
Am J Respir Crit Care Med; 2010 Nov; 182(9):1206; author reply 1206-7. PubMed ID: 21041564
[No Abstract] [Full Text] [Related]
13. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
14. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
16. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
Hoeper MM
Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
[No Abstract] [Full Text] [Related]
17. Clinical use of sildenafil in pulmonary artery hypertension.
Singh TP
Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.
Krishnan U; Krishnan S; Gewitz M
Pediatr Cardiol; 2008 Nov; 29(6):1082-6. PubMed ID: 18594787
[TBL] [Abstract][Full Text] [Related]
19. Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.
Koschel DS; Kolditz M; Höeffken G; Halank M
Med Sci Monit; 2010 May; 16(5):CS55-7. PubMed ID: 20424556
[TBL] [Abstract][Full Text] [Related]
20. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
